Zwitterionic Targeting Doxorubicin -Loaded Micelles Assembled by Amphiphilic Dendrimers with Enhanced Antitumor Performance
Langmuir · 2023
DOI: 10.1021/acs.langmuir.3c00159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Langmuir, 2023. Verfasst von Lu Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Metastable Materials Science and Technology, Hebei Key Laboratory of Nano-Biotechnology, Hebei Key Laboratory of Applied Chem…. Hauptthemen laut MEDLINE: Dendrimers, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province, Hebei Key Laboratory of Applied Chemistry.
Abstract (Originalsprache)
Chemotherapy is the main method of treating malignant tumors in clinical treatment. However, the commonly used chemotherapeutic drugs have the disadvantages of high biological toxicity, poor water solubility, low targeting ability, and high side effects. Zwitterionic micelles assembled by amphiphilic dendrimers modified with zwitterionic groups and targeting ligand should largely overcome these shortcomings. Herein, the zwitterionic group and targeting peptide c(RGDfC) were modified on the surface of generation 2 poly(propylene imine) dendrimers (G2 PPI), which was conjugated with hydrophobic N-(2-mercaptoethyl) oleamide to form amphiphilic dendrimers (PPIMYRC). PPIMYRC self-assembled into micelles with doxorubicin (DOX) loaded in the interior of micelles to prepare DOX-loaded micelles (PPIMYRC-DOX micelles). The PPIMYRC-DOX micelles had great stability in fibrinogen and pH-responsive drug release. Furthermore, PPIMYRC-DOX micelles had higher cellular uptake rates than free DOX, resulting in higher cytotoxicity of PPIMYRC-DOX micelles than that of free DOX. More importantly, PPIMYRC-DOX micelles inhibited tumors much better than free DOX. The tumor inhibition rate of PPIMYRC-DOX micelles was as high as 93%. Taken together, PPIMYRC-DOX micelles were assembled by amphiphilic dendrimers with the zwitterionic and targeting groups, which enhanced the therapeutic effect of DOX and reduced its side effects. The prepared targeting nanodrug has great potential for further application in antitumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Metastable Materials Science and Technology, Hebei Key Laboratory of Nano-Biotechnology, Hebei Key Laboratory of Applied Chemistry, Yanshan University, Qinhuangdao 066004, China.
- School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.
- Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton SO166YD, U.K.
ORCID-Profile: Guanglong Ma, Qiurong Li, Longgang Wang
Förderung
- Natural Science Foundation of Hebei Province
- Hebei Key Laboratory of Applied Chemistry
Zitieren
APA
Zhang, L., Guo, Q., Zheng, R., Yu, Q., Liang, Y., Ma, G., Li, Q., Zhang, X., Xiao, H., & Wang, L. (2023). Zwitterionic Targeting Doxorubicin -Loaded Micelles Assembled by Amphiphilic Dendrimers with Enhanced Antitumor Performance. Langmuir. https://doi.org/10.1021/acs.langmuir.3c00159
Vancouver
Zhang L, Guo Q, Zheng R, Yu Q, Liang Y, Ma G, et al. Zwitterionic Targeting Doxorubicin -Loaded Micelles Assembled by Amphiphilic Dendrimers with Enhanced Antitumor Performance. Langmuir. 2023. doi:10.1021/acs.langmuir.3c00159
BibTeX
@article{Zhang2023,
author = {Zhang, Lu and Guo, Quanling and Zheng, Ruixue and Yu, Qingyu and Liang, Ying and Ma, Guanglong and Li, Qiurong and Zhang, Xiaoyu and Xiao, Haiyan and Wang, Longgang},
title = {Zwitterionic Targeting Doxorubicin -Loaded Micelles Assembled by Amphiphilic Dendrimers with Enhanced Antitumor Performance},
journal = {Langmuir},
year = {2023},
doi = {10.1021/acs.langmuir.3c00159}
}
EUVIMED